Evidence map›Paper›PMID 25446888›Full record

ArticleBone2015

Loss of the PGE2 receptor EP1 enhances bone acquisition, which protects against age and ovariectomy-induced impairments in bone strength.

Minjie Zhang, Marina Feigenson, Tzong-jen Sheu, Hani A Awad, Edward M Schwarz, Jennifer H Jonason, Alayna E Loiselle, Regis J O'Keefe

Open access · greenAbstract read
In one paragraph

Article in Bone, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Regulatory Effect of PGEBiomolecules · 2025
    Article
  2. Old Mice Have Less Transcriptional Activation But Similar Periosteal Cell Proliferation Compared to Young-Adult Mice in Response to in vivo Mechanical Loading.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Minjie ZhangCenter for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, United States.
Marina FeigensonCenter for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, United States.
Tzong-jen SheuCenter for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, United States.
Hani A AwadCenter for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, United States; Department of Biomedical Engineering, University of Rochester, Rochester, NY 14627, United States.
Edward M SchwarzCenter for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, United States.
Jennifer H JonasonCenter for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, United States.
Alayna E LoiselleCenter for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, United States.
Regis J O'KeefeCenter for Musculoskeletal Research, Department of Orthopaedics & Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, United States; Department of Orthopaedic Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, United States. Electronic address: okeefer@wudosis.wustl.edu.
University of Rochester Medical Center · US

Funding

Translating PTH Therapy as an Adjuvant for Structural AllograftingP50AR054041 · NIAMS · UNIVERSITY OF ROCHESTER · PI O'KEEFE, REGIS J · 2006 to 2016
$15.7M
Cyclooxygenases in Skeletal RepairR01AR048681 · NIAMS · UNIVERSITY OF ROCHESTER · PI O'KEEFE, REGIS J, ZHANG, XINPING · 2003 to 2013
$3.3M
Prostaglandin Signaling in Wear Debris-induced OsteolysisR01AR046545 · NIAMS · UNIVERSITY OF ROCHESTER · PI O'KEEFE, REGIS J · 2000 to 2009
$3.0M
The University of Rochester Core Center for Musculoskeletal Biology and MedicineP30AR061307 · NIAMS · UNIVERSITY OF ROCHESTER · PI SCHWARZ, EDWARD M. · 2011 to 2015
$3.0M
NIAMS NIH HHS NIH/NIAMS P30 AR061307NIAMS NIH HHS NIH/NIAMS R01AR048681-06A1NIAMS NIH HHS P30 AR061307NIAMS NIH HHS P50 AR054041NIAMS NIH HHS R01 AR046545NIAMS NIH HHS R01 AR048681
6 · The paper itself

Abstract

PGE2 exerts anabolic and catabolic effects on bone through the discrete actions of four prostanoid receptors (EP1-4). We have previously demonstrated that loss EP1 accelerates fracture repair by enhancing bone formation. In the present study we defined the role of EP1 in bone maintenance and homeostasis during aging and in response to ovariectomy. The femur and L4 vertebrae of wild type (WT) and EP1(-/-) mice were examined at 2-months, 6-months, and 1-year of age, and in WT and EP1(-/-) mice following ovariectomy (OVX) or sham surgery. Bone volume fraction, trabecular architecture and mechanical properties were maintained during aging in EP1(-/-) mice to a greater degree than age-matched WT mice. Moreover, significant increases in bone formation rate (BFR) (+60%) and mineral apposition rate (MAR) (+50%) were observed in EP1(-/-), relative to WT, while no change in osteoclast number and osteoclast surface were observed. Following OVX, loss of EP1 was protective against bone loss in both femur and L4 vertebrae, with increased bone volume/total volume (BV/TV) (+32% in femur) and max load at failure (+10% in femur) relative to WT OVX, likely resulting from the increased bone formation rate that was observed in these mice. Taken together these studies identify inhibition of EP1 as a potential therapeutic approach to suppress bone loss in aged or post-menopausal patients.

Indexed as

AgingAnimalsBone and BonesCell DifferentiationFemaleHomeostasisMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMicroscopy, FluorescenceOsteoclastsOvariectomyReceptors, Prostaglandin E, EP1 SubtypeSignal TransductionPtger1 protein, mouseReceptors, Prostaglandin E, EP1 SubtypeAge-related bone lossBone homeostasisEP1Mouse modelOvariectomyPGE2

Identifiers

PMID25446888
PMCPMC4437532
OpenAlexW2141613765

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.